Respiratory Syncytial Virus, Felvizumab Biosimilar

Size

£544.00

SKU:: 591860
Purity:: ≥95% (reducing SDS-PAGE, HPLC). Endotoxin: ≤1EU/mg (LAL)
Storage Conditions:: -20°C
Supplier:: United States Biological
Host:: Human
Immunogen:: Recombinant protein corresponding to human Respiratory Syncytial Virus (RSV) felvizumab biosimilar, produced in mammalian cells.
Format:: Supplied as a 0.2uM filtered solution, pH 7.4. No stabilizers or preservatives added.
Extra Details:: Felvizumab Biosimilar uses the same protein sequences as the therapeutic antibody felvizumab. Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus. Applications: Suitable for use in ELISA, Neutralization, Functional Assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by Felvizumab. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.